We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.
Agenda
Agenda subject to change.
Additional faculty to be confirmed.
Friday, April 24
Times provided are in Pacific Standard Time.
Time
Topic
6:00 PM - 7:00 PM
Welcome Reception
Saturday, April 25
Time
Topic
7:30 AM - 8:30 AM
Breakfast
8:30 AM
Welcome, Introductions, and Presession Survey
8:40 AM
My Evolving Management of Patients With Smoldering MM
9:05 AM
Q&A Session
9:15 AM
My Evolving Management of Transplant-Eligible
and -Ineligible Patients With NDMM
9:40 AM
Q&A Session
9:50 AM
Case-Based Panel: Management of Patients With SMM and NDMM
10:10 AM
Morning Break
10:25 AM
Optimal Timing for and Selection of CAR T-cell Therapy
10:45 AM
Optimal Timing for and Selection of Bispecific Antibody Therapy
11:05 AM
Optimal Timing for and Selection of Non-T-Cell Redirection Therapies
11:25 AM
Q&A Session
11:35 AM
Case-Based Panel: Management of Patients With RRMM
12:05 PM
Lunch
1:00 PM
Keynote: Administration of Bispecific Antibodies for Patients With Multiple Myeloma
1:25 PM
Keynote: Administration of Bispecific Antibodies for Patients With Other Hematologic Malignancies
1:50 PM
Q&A Session
2:00 PM
Case-Based Panel: Management of Patients Receiving Bispecific Antibody Therapy
2:25 PM
Postsession Survey
2:30 PM
Program Adjourns